Spot Biosystems announced its launch from stealth with $40 million in venture financing, along with preclinical research published in Nature Biomedical Engineering and an ongoing first-in-human clinical trial for Duchenne muscular dystrophy. The company is developing a non-viral extracellular vesicle ...
Read More »
Exosome RNA Exosome RNA Research & Industry News
